Evidence map›Paper›PMID 23618427›Full record

ArticleBioPsychoSocial medicine2013

Psychosocial and cognitive function in children with nephrotic syndrome: association with disease and treatment variables.

Panagiota Manti, George Giannakopoulos, Elena Giouroukou, Helen Georgaki-Angelaki, Constantinos J Stefanidis, Andromahi Mitsioni, Nikolaos Stergiou, Constantinos Mihas, George P Chrousos, Maria Alexandra Magiakou and 1 more

Open access · goldAbstract read
In one paragraph

Article in BioPsychoSocial medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Disease-Associated Systemic Complications in Childhood Nephrotic Syndrome: A Systematic Review.International journal of nephrology and renovascular disease · 2022
    Article
  11. Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence?Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2021
    Review
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Panagiota MantiFaculty of Health and Caring Professions, 2nd Department of Nursing, Technological Educational Institution of Athens, Athens, Greece.
George GiannakopoulosDepartment of Child Psychiatry, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens 11527, Greece.
Elena GiouroukouDepartment of Child Psychiatry, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens 11527, Greece.
Helen Georgaki-AngelakiDepartment of Pediatric Nephrology, "Aghia Sophia" Children's Hospital, Athens, Greece.
Constantinos J StefanidisDepartment of Pediatric Nephrology, "P. & A. Kyriakou" Children's Hospital, Athens, Greece.
Andromahi MitsioniDepartment of Pediatric Nephrology, "P. & A. Kyriakou" Children's Hospital, Athens, Greece.
Nikolaos StergiouDepartment of Pediatric Nephrology, "Aghia Sophia" Children's Hospital, Athens, Greece.
Constantinos MihasDepartment of Child Psychiatry, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens 11527, Greece.
George P ChrousosDivision of Endocrinology, Metabolism and Diabetes, 1st Department of Pediatrics, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens, Greece.
Maria Alexandra Magiakou *Division of Endocrinology, Metabolism and Diabetes, 1st Department of Pediatrics, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens, Greece.
Gerasimos Kolaitis *Department of Child Psychiatry, "Aghia Sophia" Children's Hospital, University of Athens Medical School, Athens 11527, Greece.
Children's Hospital Agia Sophia · GRNational and Kapodistrian University of Athens · GRPanagiotis & Aglaia Kyriakou Children's Hospital · GRTechnological Educational Institute of Athens · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo investigate possible differences in emotional/behavioral problems and cognitive function in children with nephrotic syndrome compared to healthy controls and to examine the effect of disease-specific and steroid treatment-specific characteristics on the abovementioned variables.

methodsForty-one patients with nephrotic syndrome (23 boys, age range: 4.4-15.2 years) and 42 sex- and age-matched healthy control subjects (20 boys, age range: 4.1-13.4 years) were enrolled in the study. Disease (severity, age of diagnosis, duration) and steroid treatment (total duration, present methylprednisolone dose and duration of present dose) data were collected. In order to assess children's emotional/behavioral problems, the Child Behavior Checklist was administered. The Wechsler Intelligence Scale for Children - Third Edition was administered to assess Full-Scale, Verbal, and Performance intelligence quotient (IQ) scores.

resultsThe patients presented with more internalizing problems (P = 0.015), including withdrawal (P = 0.012) and somatic complaints (P = 0 .011), but not more anxiety/depression or externalizing problems. A significant association was found between severity of disease and somatic complaints (P = 0.017) as well as externalizing problems (P = 0.030). Years of illness were significantly more in those presenting with abnormal anxiety/depression (P = 0.011). Duration of steroid medication was significantly higher among those presenting with abnormal anxiety/depression (P = 0.011) and externalizing problems (P = 0.039). IQ was not associated significantly with disease or steroid treatment variables.

conclusionsPsychosocial factors and outcomes may be important correlates of children's nephrotic syndrome and potential targets of thorough assessment and treatment.

Identifiers

PMID23618427
PMCPMC3652787
OpenAlexW2134094448

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.